Keloid fibroblasts are more sensitive to Wnt3a treatment in terms of elevated cellular growth and fibronectin expression.

[1]  G. Mutlu,et al.  Nuclear β-catenin is increased in systemic sclerosis pulmonary fibrosis and promotes lung fibroblast migration and proliferation. , 2011, American journal of respiratory cell and molecular biology.

[2]  K. Sabapathy,et al.  The role of R-spondin2 in keratinocyte proliferation and epidermal thickening in keloid scarring. , 2011, The Journal of investigative dermatology.

[3]  Wei He,et al.  Exogenously administered secreted frizzled related protein 2 (Sfrp2) reduces fibrosis and improves cardiac function in a rat model of myocardial infarction , 2010, Proceedings of the National Academy of Sciences.

[4]  Scott M. Williams,et al.  Epigenetically altered wound healing in keloid fibroblasts. , 2010, The Journal of investigative dermatology.

[5]  P. Bovolenta,et al.  The advantages and disadvantages of sfrp1 and sfrp2 expression in pathological events. , 2010, The Tohoku journal of experimental medicine.

[6]  N. Nara,et al.  Cyclopamine and quercetin suppress the growth of leukemia and lymphoma cells. , 2009, Anticancer research.

[7]  R. Pignolo,et al.  The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling. , 2009, Cytokine & growth factor reviews.

[8]  P. Neth,et al.  Wnt signalling in mouse mesenchymal stem cells: impact on proliferation, invasion and MMP expression , 2009, Journal of cellular and molecular medicine.

[9]  Y. Akasaka,et al.  Promoted activation of matrix metalloproteinase (MMP)‐2 in keloid fibroblasts and increased expression of MMP‐2 in collagen bundle regions: implications for mechanisms of keloid progression , 2009, Histopathology.

[10]  I. Nishimoto,et al.  Anti-apoptotic action of Wnt5a in dermal fibroblasts is mediated by the PKA signaling pathways. , 2008, Cellular signalling.

[11]  W. Seeger,et al.  Functional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis , 2008, PloS one.

[12]  Scott M. Williams,et al.  Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways. , 2008, The Journal of investigative dermatology.

[13]  M. Longaker,et al.  Current progress in keloid research and treatment. , 2008, Journal of the American College of Surgeons.

[14]  Shaoqiong Chen,et al.  The gene expression profile induced by Wnt 3a in NIH 3T3 fibroblasts , 2007, Journal of Cell Communication and Signaling.

[15]  C. Zhang,et al.  Wnt3a signaling promotes proliferation, myogenic differentiation, and migration of rat bone marrow mesenchymal stem cells , 2007, Acta Pharmacologica Sinica.

[16]  M. Longaker,et al.  Increased CCN2 Transcription in Keloid Fibroblasts Requires Cooperativity Between AP-1 and SMAD Binding Sites , 2007 .

[17]  Rocky S Tuan,et al.  Canonical and non‐canonical wnts differentially affect the development potential of primary isolate of human bone marrow mesenchymal stem cells , 2007, Journal of cellular physiology.

[18]  Mala Sinha,et al.  Secreted Frizzled-Related Protein 1 Loss Contributes to Tumor Phenotype of Clear Cell Renal Cell Carcinoma , 2007, Clinical Cancer Research.

[19]  Sung-Eun Kim,et al.  EGF receptor is involved in WNT3a-mediated proliferation and motility of NIH3T3 cells via ERK pathway activation. , 2007, Cellular signalling.

[20]  D. O'Gorman,et al.  β-Catenin Signaling in Fibroproliferative Disease , 2007 .

[21]  Beibei Wu,et al.  Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. , 2007, Immunity.

[22]  M. Waterman,et al.  Diversity of LEF/TCF action in development and disease , 2006, Oncogene.

[23]  Xinmin Cao,et al.  Stat3 contributes to keloid pathogenesis via promoting collagen production, cell proliferation and migration , 2006, Oncogene.

[24]  P. Neth,et al.  Wnt Signaling Regulates the Invasion Capacity of Human Mesenchymal Stem Cells , 2006, Stem cells.

[25]  U. Mrowietz,et al.  Quality of life of patients with keloid and hypertrophic scarring , 2006, Archives of Dermatological Research.

[26]  A. Ooshima,et al.  Keloid‐derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration , 2005, The British journal of dermatology.

[27]  Chul-hak Yang,et al.  Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells. , 2005, Biochemical and biophysical research communications.

[28]  B. Alman,et al.  Prolonged β-catenin stabilization and tcf-dependent transcriptional activation in hyperplastic cutaneous wounds , 2005, Laboratory Investigation.

[29]  S. Jeon,et al.  Both ERK and Wnt/β-catenin pathways are involved in Wnt3a-induced proliferation , 2005, Journal of Cell Science.

[30]  D. Kerr,et al.  Signal transduction blockade and cancer: combination therapy or multi-targeted inhibitors? , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  M. Longaker,et al.  Suppression of transforming growth factor beta/smad signaling in keloid-derived fibroblasts by quercetin: implications for the treatment of excessive scars. , 2004, The Journal of trauma.

[32]  T. Brabletz,et al.  β‐Catenin activates a coordinated expression of the proinvasive factors laminin‐5 γ2 chain and MT1‐MMP in colorectal carcinomas , 2004 .

[33]  B. Alman,et al.  Elevated levels of β-catenin and fibronectin in three-dimensional collagen cultures of Dupuytren's disease cells are regulated by tension in vitro , 2003, BMC Musculoskeletal Disorders.

[34]  Yoshiaki Kawano,et al.  Secreted antagonists of the Wnt signalling pathway , 2003, Journal of Cell Science.

[35]  H. Huynh,et al.  Suppression of insulin‐like growth factor signalling pathway and collagen expression in keloid‐derived fibroblasts by quercetin: its therapeutic potential use in the treatment and/or prevention of keloids , 2003, The British journal of dermatology.

[36]  Yusuke Nakamura,et al.  Identification of membrane-type matrix metalloproteinase-1 as a target of the β-catenin/Tcf4 complex in human colorectal cancers , 2002, Oncogene.

[37]  F. Wood,et al.  [International clinical recommendations on scar management]. , 2002, Zentralblatt fur Chirurgie.

[38]  K. Shimotohno,et al.  Wnt/β‐catenin signaling suppresses apoptosis in low serum medium and induces morphologic change in rodent fibroblasts , 2002, International journal of cancer.

[39]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[40]  M Kon,et al.  On the nature of hypertrophic scars and keloids: a review. , 1999, Plastic and reconstructive surgery.

[41]  Doris Wedlich,et al.  The Wnt/Wg Signal Transducer β-Catenin Controls Fibronectin Expression , 1999, Molecular and Cellular Biology.

[42]  M. Yamauchi,et al.  Altered posttranslational modifications of collagen in keloid. , 1998, Biochemical and biophysical research communications.

[43]  R. Tuan,et al.  Major suppression of pro-alpha1(I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide. , 1997, Journal of the American Academy of Dermatology.

[44]  Gary R. Grotendorst,et al.  Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. , 1996, The Journal of investigative dermatology.

[45]  A. Banes,et al.  Increased proliferation in keloid fibroblasts wounded in vitro. , 1996, The Journal of surgical research.

[46]  R. Diegelmann,et al.  Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing , 1989, Molecular and cellular biology.

[47]  J. Uitto,et al.  Altered steady-state ratio of type I/III procollagen mRNAs correlates with selectively increased type I procollagen biosynthesis in cultured keloid fibroblasts. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[48]  M. Hendrix,et al.  Fibronectin (FN) in hypertrophic scars and keloids , 1983, Cell and Tissue Research.

[49]  Madoka Sato.  Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids. , 2006, Acta dermato-venereologica.

[50]  T. Tuan,et al.  The molecular basis of keloid and hypertrophic scar formation. , 1998, Molecular medicine today.